Detalhe da pesquisa
1.
Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate.
Trop Med Int Health
; 23(10): 1110-1117, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30053341
2.
Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
J Antimicrob Chemother
; 70(12): 3283-90, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26346991
3.
Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment.
Pharmaceutics
; 16(4)2024 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38675171
4.
A new oral self-emulsifying drug delivery system improves the antileishmania efficacy of fexinidazole in vivo.
Int J Pharm
; 631: 122505, 2023 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36549405
5.
Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
Antimicrob Agents Chemother
; 54(11): 4699-704, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20713665
6.
Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
J Antimicrob Chemother
; 64(6): 1234-40, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19825819
7.
Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis.
Photodiagnosis Photodyn Ther
; 28: 210-215, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31454712
8.
Drug delivery systems for the topical treatment of cutaneous leishmaniasis.
Expert Opin Drug Deliv
; 9(9): 1083-97, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22724539